TTD_Target_ID	Target_Name	TTD_Drug_ID	Drug_Name	Drug_Highest_Status	Drug_PubchemID	Molecular_Formula	Molecular_Weight	Canonical_SMILES	Activity	Binder_Type
T37693	Cannabinoid receptor 2	D0O3OS	SR141716A	Approved	104850	C22H21Cl3N4O	463.8	CC1=C(N(N=C1C(=O)NN2CCCCC2)C3=C(C=C(C=C3)Cl)Cl)C4=CC=C(C=C4)Cl	Ki = 2511886.43 nM	Non binder
T37693	Cannabinoid receptor 2	B9WPV1	N-(1-Adamantyl)-4-oxo-1-pentyl-6-(2-phenylethynyl)quinoline-3-carboxamide	Investigative	46915339	C33H36N2O2	492.6	CCCCCN1C=C(C(=O)C2=C1C=CC(=C2)C#CC3=CC=CC=C3)C(=O)NC45CC6CC(C4)CC(C6)C5	Ki = 2951209.23 nM	Non binder
T37693	Cannabinoid receptor 2	BAR3F2	Dibenzo[b,f][1,4]thiazepine-8-carboxamide, N-butyl-11-(3-chloro-4-fluorophenyl)-	Investigative	42596959	C24H20ClFN2OS	438.9	CCCCNC(=O)C1=CC2=C(C=C1)SC3=CC=CC=C3C(=N2)C4=CC(=C(C=C4)F)Cl	Ki = 1000000 nM	Non binder
T37693	Cannabinoid receptor 2	BEC34F	6-Bromo-N-hexyl-4-oxo-1-pentylquinoline-3-carboxamide	Investigative	46915774	C21H29BrN2O2	421.4	CCCCCCNC(=O)C1=CN(C2=C(C1=O)C=C(C=C2)Br)CCCCC	Ki = 1122018.45 nM	Non binder
T37693	Cannabinoid receptor 2	BHR97T	N3-(1-Naphthyl)-1-butyl-4-oxo-1,4-dihydroquinoline-3-carboxamide	Investigative	11559736	C24H22N2O2	370.4	CCCCN1C=C(C(=O)C2=CC=CC=C21)C(=O)NC3=CC=CC4=CC=CC=C43	Ki = 2187761.62 nM	Non binder
T37693	Cannabinoid receptor 2	BJDL79	Pyrazole-3-carboxamide analogue, 29	Investigative	24768472	C22H16Cl4N4O	494.2	CC1=C(N(N=C1C(=O)NCC2=CC(=C(C=C2)Cl)Cl)C3=CC(=C(C=C3)Cl)Cl)N4C=CC=C4	Ki = 6606934.48 nM	Non binder
T37693	Cannabinoid receptor 2	BKGR10	N-(1-Adamantyl)-6-[(2,4-dichlorophenyl)methyl]-4-oxo-1-pentylquinoline-3-carboxamide	Investigative	46914722	C32H36Cl2N2O2	551.5	CCCCCN1C=C(C(=O)C2=C1C=CC(=C2)CC3=C(C=C(C=C3)Cl)Cl)C(=O)NC45CC6CC(C4)CC(C6)C5	Ki = 257039.58 nM	Non binder
T37693	Cannabinoid receptor 2	BL62TJ	(E)-N-(Adamant-1-yl)-6-[2-(4-methoxyphenyl)vinyl]-4-oxo-1-pentyl-1,4-dihydroquinoline-3-carboxamide	Investigative	25034659	C34H40N2O3	524.7	CCCCCN1C=C(C(=O)C2=C1C=CC(=C2)/C=C/C3=CC=C(C=C3)OC)C(=O)NC45CC6CC(C4)CC(C6)C5	Ki = 17782794.1 nM	Non binder
T37693	Cannabinoid receptor 2	BN3V8J	N-(1-Adamantyl)-6-(3,5-dimethyl-1,2-oxazol-4-yl)-4-oxo-1-pentylquinoline-3-carboxamide	Investigative	46915021	C30H37N3O3	487.6	CCCCCN1C=C(C(=O)C2=C1C=CC(=C2)C3=C(ON=C3C)C)C(=O)NC45CC6CC(C4)CC(C6)C5	Ki = 9772372.21 nM	Non binder
T37693	Cannabinoid receptor 2	BP59TY	N-Cyclohexyl-1-(2,4-dichlorophenyl)-6-methyl-4H-indeno[1,2-c]pyrazole-3-carboxamide	Investigative	16094766	C24H23Cl2N3O	440.4	CC1=CC2=C(C=C1)C3=C(C2)C(=NN3C4=C(C=C(C=C4)Cl)Cl)C(=O)NC5CCCCC5	Ki = 131825673.9 nM	Non binder
T37693	Cannabinoid receptor 2	BQJX25	2-(2-Chlorophenyl)-3-(4-chlorophenyl)-6-(2-methylpropyl)-4,5-dihydropyrazolo[3,4-c]pyridin-7-one	Investigative	42617977	C22H21Cl2N3O	414.3	CC(C)CN1CCC2=C(N(N=C2C1=O)C3=CC=CC=C3Cl)C4=CC=C(C=C4)Cl	Ki = 562341.33 nM	Non binder
T37693	Cannabinoid receptor 2	BQZ36N	1-Butanesulfonic acid, 4,4,4-trifluoro-, 3-(((2R)-2,3-dihydro-2-(hydroxymethyl)-1H-inden-4-yl)oxy)phenyl ester	Investigative	9845561	C20H21F3O5S	430.4	C1[C@H](CC2=C1C=CC=C2OC3=CC(=CC=C3)OS(=O)(=O)CCCC(F)(F)F)CO	Ki = 234422881.5 nM	Non binder
T37693	Cannabinoid receptor 2	BWVB36	N-(1-Adamantyl)-4-oxo-1-pentyl-6-(4-phenylphenyl)quinoline-3-carboxamide	Investigative	46915338	C37H40N2O2	544.7	CCCCCN1C=C(C(=O)C2=C1C=CC(=C2)C3=CC=C(C=C3)C4=CC=CC=C4)C(=O)NC56CC7CC(C5)CC(C7)C6	Ki = 5623413.25 nM	Non binder
T37693	Cannabinoid receptor 2	D08YQT	AM251	Investigative	2125	C22H21Cl2IN4O	555.2	CC1=C(N(N=C1C(=O)NN2CCCCC2)C3=C(C=C(C=C3)Cl)Cl)C4=CC=C(C=C4)I	Ki = 8912509.38 nM	Non binder